Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene
The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Abstract
Acute myeloid leukaemia (AML) is a major haematopoietic malignancy characterized by the proliferation of a malignant clone of myeloid progenitor cells. A reciprocal translocation, t(8;21)(q22;q22), observed in the leukaemic cells of approximately 40% of patients with the M2 subtype of AML disrupts both the AML1 (CBFA2) gene on chromosome 21 and the ETO (MTG8) gene on chromosome 8 (refs 3-5). A chimaeric protein is synthesized from one of the derivative chromosomes that contains the N terminus of the AML1 transcription factor, including its DNA-binding domain, fused to most of ETO, a protein of unknown function. We generated mice that mimic human t(8;21) with a "knock-in' strategy. Mice heterozygous for an AML1-ETO allele (AML1-ETO/+) die in midgestation from haemorrhaging in the central nervous system and exhibit a severe block in fetal liver haematopoiesis. This phenotype is very similar to that resulting from homozygous disruption of the AML1 (Cbfa2) or Cbfb genes, indicating that AML1-ETO blocks normal AML1 function. However, yolk sac cells from AML1-ETO/+ mice differentiated into macrophages in haematopoietic colony forming unit (CFU) assays, unlike Cbfa2-/- or Cbfb-/-cells, which form no colonies in vitro. This indicates that AML1-ETO may have other functions besides blocking wild-type AML1, a property that may be important in leukaemogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, AML1-ETO and inv (16) transgenic mice display a phenotype similar to that of AML-1 (CBF-␣)-and CBF--deficient mice, as they die during embryogenesis from central nervous system hemorrhages and exhibit severe blocks in fetal liver hematopoiesis (6,52,69,70,74).”
From The t(8;21) Fusion Product, AML-1–ETO, Associates with C/EBP-α, Inhibits C/EBP-α-Dependent Transcription, and Blocks Granulocytic Differentiation (1998) · cites this paper as [74]
In the citing paper
“These results were corroborated by the generation of AML-1-ETO”
From The t(8;21) Fusion Product, AML-1–ETO, Associates with C/EBP-α, Inhibits C/EBP-α-Dependent Transcription, and Blocks Granulocytic Differentiation (1998) · cites this paper as [74]
In the citing paper
“RUNX1 is frequently inactivated by mutation or translocation in the myeloid cancers myelodysplastic syndrome and acute myeloid leukemia (AML)3 (∼20% of cases)”
From Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy (2014) · cites this paper as [7]
Citations
Cites
Targeted mutation of the DNA methyltransferase gene results in embryonic lethality
Li, E., Bestor, T. H., & Jaenisch, R. (1992) · Cell · doi:10.1016/0092-8674(92)90611-f · Cited by 3,984
Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., & Downing, J. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80986-1 · Cited by 1,856
Altering the Genome by Homologous Recombination
Capecchi, M. R. (1989) · Science · doi:10.1126/science.2660260 · Cited by 1,594
An early haematopoietic defect in mice lacking the transcription factor GATA-2
Tsai, F.-Y., Keller, G., Kuo, F. C., Weiss, M., Chen, J., Rosenblatt, M., Alt, F. W., & Orkin, S. H. (1994) · Nature · doi:10.1038/371221a0 · Cited by 1,237
Wang, Q., Stacy, T., Binder, M., Marin-Padilla, M., Sharpe, A. H., & Speck, N. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3444 · Cited by 1,178
Self-citationMiyoshi, H., Shimizu, K., Kozu, T., Maseki, N., Kaneko, Y., & Ohki, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10431 · Cited by 872
Fusion Between Transcription Factor CBFβ/PEBP2β and a Myosin Heavy Chain in Acute Myeloid Leukemia
Liu, P., Tarlé, S. A., Hajra, A., Claxton, D. F., Marlton, P., Freedman, M., Siciliano, M. J., & Collins, F. S. (1993) · Science · doi:10.1126/science.8351518 · Cited by 732
Erickson, P., Gao, J., Chang, K., Look, T., Whisenant, E., Raimondi, S., Lasher, R., Trujillo, J., Rowley, J., & Drabkin, H. (1992) · Blood · doi:10.1182/blood.v80.7.1825.1825 · Cited by 631
The CBFβ Subunit Is Essential for CBFα2 (AML1) Function In Vivo
Wang, Q., Stacy, T., Miller, J. D., Lewis, A. F., Gu, T.-L., Huang, X., Bushweller, J. H., Bories, J.-C., Alt, F. W., Ryan, G., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81389-6 · Cited by 621
Self-citationGiese, K., Kingsley, C., Kirshner, J. R., & Grosschedl, R. (1995) · Genes & Development · doi:10.1101/gad.9.8.995 · Cited by 541
Research works printed but not linked: 1
- Rowley, J.D. Biological implications of consistent chromosome rearrangements in leukemia and lymphoma. Cancer Res. 44, 3159–3168 (1984).
Cited by
The roles of FLT3 in hematopoiesis and leukemia
Gilliland, D. G., & Griffin, J. D. (2002) · Blood · doi:10.1182/blood-2002-02-0492 · Cited by 1,558
Song, W.-J., Sullivan, M. G., Legare, R. D., Hutchings, S., Tan, X., Kufrin, D., Ratajczak, J., Resende, I. C., Haworth, C., Hock, R., et al. (1999) · Nature Genetics · doi:10.1038/13793 · Cited by 1,100
“30 ) that lack sequences C terminal to the Runt domain required for trans -activation, as well as for the protein products of chromosomal translocations involving CBFA2 in human leukaemia”
BackgroundSelf-citationTranscription Factors, Normal Myeloid Development, and Leukemia
Tenen, D. G., Hromas, R., Licht, J. D., & Zhang, D.-E. (1997) · Blood · doi:10.1182/blood.v90.2.489 · Cited by 735
Self-citationCore-binding factors in haematopoiesis and leukaemia
Speck, N. A., & Gilliland, D. G. (2002) · Nature Reviews Cancer · doi:10.1038/nrc840 · Cited by 569
Self-citationG ENETICS OF M YELOID L EUKEMIAS
Kelly, L. M., & Gilliland, D. G. (2002) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.3.032802.115046 · Cited by 523
Wang, J., Hoshino, T., Redner, R. L., Kajigaya, S., & Liu, J. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10860 · Cited by 512
Role of RUNX1 in hematological malignancies
Sood, R., Kamikubo, Y., & Liu, P. (2017) · Blood · doi:10.1182/blood-2016-10-687830 · Cited by 494
Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins
Ayton, P. M., & Cleary, M. L. (2001) · Oncogene · doi:10.1038/sj.onc.1204639 · Cited by 500
Gelmetti, V., Zhang, J., Fanelli, M., Minucci, S., Pelicci, P. G., & Lazar, M. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.12.7185 · Cited by 491
Miyamoto, T., Weissman, I. L., & Akashi, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7521 · Cited by 465
AML1–ETO downregulates the granulocytic differentiation factor C/EBPα in t(8;21) myeloid leukemia
Pabst, T., Mueller, B. U., Harakawa, N., Schoch, C., Haferlach, T., Behre, G., Hiddemann, W., Zhang, D.-E., & Tenen, D. G. (2001) · Nature Medicine · doi:10.1038/86515 · Cited by 463
Self-citationLoss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype
Growney, J. D., Shigematsu, H., Li, Z., Lee, B. H., Adelsperger, J., Rowan, R., Curley, D. P., Kutok, J. L., Akashi, K., Williams, I. R., et al. (2005) · Blood · doi:10.1182/blood-2004-08-3280 · Cited by 462
Self-citationThe runx genes: gain or loss of function in cancer
Blyth, K., Cameron, E. R., & Neil, J. C. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1607 · Cited by 455
Fröhling, S., Schlenk, R. F., Stolze, I., Bihlmayr, J., Benner, A., Kreitmeier, S., Tobis, K., Döhner, H., & Döhner, K. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.060 · Cited by 458
Higuchi, M., O'Brien, D., Kumaravelu, P., Lenny, N., Yeoh, E.-J., & Downing, J. R. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00016-8 · Cited by 440
ETO, a Target of t(8;21) in Acute Leukemia, Interacts with the N-CoR and mSin3 Corepressors
Lutterbach, B., Westendorf, J. J., Linggi, B., Patten, A., Moniwa, M., Davie, J. R., Huynh, K. D., Bardwell, V. J., Lavinsky, R. M., Rosenfeld, M. G., et al. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.12.7176 · Cited by 434
Yuan, Y., Zhou, L., Miyamoto, T., Iwasaki, H., Harakawa, N., Hetherington, C. J., Burel, S. A., Lagasse, E., Weissman, I. L., Akashi, K., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171321298 · Cited by 431
Self-citationSecondary leukemias induced by topoisomerase-targeted drugs
Felix, C. A. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00139-0 · Cited by 418
THE CRITICAL ROLE OF CHROMOSOME TRANSLOCATIONS IN HUMAN LEUKEMIAS
Rowley, J. D. (1998) · Annual Review of Genetics · doi:10.1146/annurev.genet.32.1.495 · Cited by 397
Osato, M., Asou, N., Abdalla, E., Hoshino, K., Yamasaki, H., Okubo, T., Suzushima, H., Takatsuki, K., Kanno, T., Shigesada, K., et al. (1999) · Blood · doi:10.1182/blood.v93.6.1817.406k36_1817_1824 · Cited by 397
Okuda, T., Cai, Z., Yang, S., Lenny, N., Lyu, C.-J., van Deursen, J. M. A., Harada, H., & Downing, J. R. (1998) · Blood · doi:10.1182/blood.v91.9.3134 · Cited by 372
Interferon-Stimulated Gene 15 and the Protein ISGylation System
Zhang, D., & Zhang, D.-E. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0110 · Cited by 355
Self-citationGenetics of Myeloid Malignancies: Pathogenetic and Clinical Implications
Fröhling, S., Scholl, C., Gilliland, D. G., & Levine, R. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.010 · Cited by 353
Pratap, J., Javed, A., Languino, L. R., van Wijnen, A. J., Stein, J. L., Stein, G. S., & Lian, J. B. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.19.8581-8591.2005 · Cited by 312
Castilla, L. H., Garrett, L., Adya, N., Orlic, D., Dutra, A., Anderson, S., Owens, J., Eckhaus, M., Bodine, D., & Liu, P. P. (1999) · Nature Genetics · doi:10.1038/13776 · Cited by 302
The 8;21 translocation in leukemogenesis
Peterson, L. F., & Zhang, D.-E. (2004) · Oncogene · doi:10.1038/sj.onc.1207727 · Cited by 302
Self-citationKalev-Zylinska, M. L., Horsfield, J. A., Flores, M. V. C., Postlethwait, J. H., Vitas, M. R., Baas, A. M., Crosier, P. S., & Crosier, K. E. (2002) · Development · doi:10.1242/dev.129.8.2015 · Cited by 289
Yan, M., Kanbe, E., Peterson, L. F., Boyapati, A., Miao, Y., Wang, Y., Chen, I.-M., Chen, Z., Rowley, J. D., Willman, C. L., et al. (2006) · Nature Medicine · doi:10.1038/nm1443 · Cited by 279
“, although AE has been reported to block AML1 function during embryonic developmen”
BackgroundSelf-citationPoint mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia
Osato, M. (2004) · Oncogene · doi:10.1038/sj.onc.1207779 · Cited by 268
Choi, J.-Y., Pratap, J., Javed, A., Zaidi, S. K., Xing, L., Balint, E., Dalamangas, S., Boyce, B., van Wijnen, A. J., Lian, J. B., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151236498 · Cited by 272
Westendorf, J. J., Yamamoto, C. M., Lenny, N., Downing, J. R., Selsted, M. E., & Hiebert, S. W. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.322 · Cited by 270
“The AML-1B(1-290) mutant and its variants lack three of these residues but retain the major phosphorylation site, S276.”
BackgroundInfluentialAnalysis of the role of AML1-ETO in leukemogenesis, using an inducible transgenic mouse model
Rhoades, K. L., Hetherington, C. J., Harakawa, N., Yergeau, D. A., Zhou, L., Liu, L.-Q., Little, M.-T., Tenen, D. G., & Zhang, D.-E. (2000) · Blood · doi:10.1182/blood.v96.6.2108 · Cited by 257
Self-citationVangala, R. K., Heiss-Neumann, M. S., Rangatia, J. S., Singh, S. M., Schoch, C., Tenen, D. G., Hiddemann, W., & Behre, G. (2003) · Blood · doi:10.1182/blood-2002-04-1288 · Cited by 245
Self-citationJaved, A., Guo, B., Hiebert, S., Choi, J.-Y., Green, J., Zhao, S.-C., Osborne, M. A., Stifani, S., Stein, J. L., Lian, J. B., et al. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.12.2221 · Cited by 233
The hare and the tortoise: an embryonic haematopoietic race
Godin, I., & Cumano, A. (2002) · Nature Reviews Immunology · doi:10.1038/nri857 · Cited by 232
Multiple Functional Domains of AML1: PU.1 and C/EBPα Synergize with Different Regions of AML1
Petrovick, M. S., Hiebert, S. W., Friedman, A. D., Hetherington, C. J., Tenen, D. G., & Zhang, D.-E. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.3915 · Cited by 218
Self-citationDowning, J. R. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01377.x · Cited by 211
Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation
Lutterbach, B., & Hiebert, S. W. (2000) · Gene · doi:10.1016/s0378-1119(00)00014-7 · Cited by 209
The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells
Mulloy, J. C., Cammenga, J., MacKenzie, K. L., Berguido, F. J., Moore, M. A. S., & Nimer, S. D. (2002) · Blood · doi:10.1182/blood.v99.1.15 · Cited by 208
Molecular genetics of human leukemias: New insights into therapy
Gilliland, D. G. (2002) · Seminars in Hematology · doi:10.1053/shem.2002.36921 · Cited by 203
Gilliland, D. G., & Griffin, J. D. (2002) · Current Opinion in Hematology · doi:10.1097/00062752-200207000-00003 · Cited by 202
(2008) · Advances in Cancer Research · doi:10.1016/s0065-230x(07)99002-8 · Cited by 203
Lutterbach, B., Sun, D., Schuetz, J., & Hiebert, S. W. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.6.3604 · Cited by 192
(1999) · PubMed · Cited by 194
Kanno, T., Kanno, Y., Chen, L.-F., Ogawa, E., Kim, W.-Y., & Ito, Y. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2444 · Cited by 192
Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity
Zhao, X., Jankovic, V., Gural, A., Huang, G., Pardanani, A., Menendez, S., Zhang, J., Dunne, R., Xiao, A., Erdjument-Bromage, H., et al. (2008) · Genes & Development · doi:10.1101/gad.1632608 · Cited by 186
Chromatin Remodeling and Leukemia: New Therapeutic Paradigms
Redner, R. L., Wang, J., & Liu, J. M. (1999) · Blood · doi:10.1182/blood.v94.2.417 · Cited by 189
Ptasinska, A., Assi, S. A., Mannari, D., James, S. R., Williamson, D., Dunne, J., Hoogenkamp, M., Wu, M., Care, M., McNeill, H., et al. (2012) · Leukemia · doi:10.1038/leu.2012.49 · Cited by 184
Self-citationAML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML
Licht, J. D. (2001) · Oncogene · doi:10.1038/sj.onc.1204593 · Cited by 180
Gilliland, D. G., & Tallman, M. S. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00081-8 · Cited by 169
Chromatin structural elements and chromosomal translocations in leukemia
Zhang, Y., & Rowley, J. D. (2006) · DNA Repair · doi:10.1016/j.dnarep.2006.05.020 · Cited by 182
Zelent, A., Greaves, M., & Enver, T. (2004) · Oncogene · doi:10.1038/sj.onc.1207672 · Cited by 174
de Guzman, C. G., Warren, A. J., Zhang, Z., Gartland, L., Erickson, P., Drabkin, H., Hiebert, S. W., & Klug, C. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.15.5506-5517.2002 · Cited by 171
Mice Defective in Two Apoptosis Pathways in the Myeloid Lineage Develop Acute Myeloblastic Leukemia
Traver, D., Akashi, K., Weissman, I. L., & Lagasse, E. (1998) · Immunity · doi:10.1016/s1074-7613(00)80587-7 · Cited by 173
Heidenreich, O., Krauter, J., Riehle, H., Hadwiger, P., John, M., Heil, G., Vornlocher, H.-P., & Nordheim, A. (2003) · Blood · doi:10.1182/blood-2002-05-1589 · Cited by 175
Tools for targeted manipulation of the mouse genome
van der Weyden, L., Adams, D. J., & Bradley, A. (2002) · Physiological Genomics · doi:10.1152/physiolgenomics.00074.2002 · Cited by 168
Transforming growth factor-β signaling in normal and malignant hematopoiesis
Kim, S.-J., & Letterio, J. (2003) · Leukemia · doi:10.1038/sj.leu.2403069 · Cited by 166
RUNX1 and RUNX1-ETO: roles in hematopoiesis and leukemogenesis
Lam, K. (2012) · Frontiers in Bioscience · doi:10.2741/3977 · Cited by 167
“The first mouse models utilized a knock-in strategy to insert the RUNX1-ETO fusion gene into the Runx1 locus and revealed that heterozygous RUNX1-ETO mice die during embryogenesis (149,150).”
BackgroundMethodMolecular genetics of acute myeloid leukaemia
Dash, A., & Gilliland, D. G. (2001) · Best Practice & Research Clinical Haematology · doi:10.1053/beha.2000.0115 · Cited by 166
Liu, L., Ilaria, R. L., Kingsley, P. D., Iwama, A., Etten, R. A. V., Palis, J., & Zhang, D. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.3029 · Cited by 164
Self-citationThe Runx genes: lineage-specific oncogenes and tumor suppressors
Cameron, E. R., & Neil, J. C. (2004) · Oncogene · doi:10.1038/sj.onc.1207130 · Cited by 167
Melnick, A. M., Westendorf, J. J., Polinger, A., Carlile, G. W., Arai, S., Ball, H. J., Lutterbach, B., Hiebert, S. W., & Licht, J. D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.6.2075-2086.2000 · Cited by 152
Cbfβ-SMMHC induces distinct abnormal myeloid progenitors able to develop acute myeloid leukemia
Kuo, Y., Landrette, S. F., Heilman, S. A., Perrat, P. N., Garrett, L. J., Liu, P. P., Beau, M. M. L., Kogan, S. C., & Castilla, L. H. (2006) · Cancer Cell · doi:10.1016/j.ccr.2005.12.014 · Cited by 159
Schwieger, M., Löhler, J., Friel, J., Scheller, M., Horak, I., & Stocking, C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020824 · Cited by 143
Dichotomy of AML1-ETO Functions: Growth Arrest versus Block of Differentiation
Burel, S. A., Harakawa, N., Zhou, L., Pabst, T., Tenen, D. G., & Zhang, D.-E. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.16.5577-5590.2001 · Cited by 142
Self-citationAdya, N., Stacy, T., Speck, N. A., & Liu, P. P. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.12.7432 · Cited by 136
“AML1-ETO can also dominantly suppress CBF function, as shown in a mouse knock-in model (38, 55).”
BackgroundSelf-citationC-KIT mutation cooperates with full-length AML1-ETO to induce acute myeloid leukemia in mice
Wang, Y., Zhao, L., Wu, C., Liu, P., Shi, L., Liang, Y., Xiong, S.-M., Mi, J., Chen, Z., Ren, R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019625108 · Cited by 135
Forster, A. M., Pannell, R., Drynan, L. F., McCormack, M. P., Collins, E. C., Daser, A., & Rabbitts, T. H. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00106-5 · Cited by 134
Addiction of t(8;21) and inv(16) Acute Myeloid Leukemia to Native RUNX1
Ben-Ami, O., Friedman, D., Leshkowitz, D., Goldenberg, D., Orlovsky, K., Pencovich, N., Lotem, J., Tanay, A., & Groner, Y. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.08.020 · Cited by 132
The versatile mixed lineage leukaemia gene MLL and its many associations in leukaemogenesis
Daser, A., & Rabbitts, T. H. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.01.007 · Cited by 131
Mao, S., Frank, R. C., Zhang, J., Miyazaki, Y., & Nimer, S. D. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3635 · Cited by 129
The inv(16) encodes an acute myeloid leukemia 1 transcriptional corepressor
Lutterbach, B. A., Hou, Y., Durst, K. L., & Hiebert, S. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12822 · Cited by 135
Yan, M., Burel, S. A., Peterson, L. F., Kanbe, E., Iwasaki, H., Boyapati, A., Hines, R., Akashi, K., & Zhang, D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406702101 · Cited by 137
Self-citationAML1 deletion in adult mice causes splenomegaly and lymphomas
Putz, G., Rosner, A., Nuesslein, I., Schmitz, N., & Buchholz, F. (2005) · Oncogene · doi:10.1038/sj.onc.1209136 · Cited by 132
Andreasson, P., Schwaller, J., Anastasiadou, E., Aster, J. C., & Gilliland, D. G. (2001) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(01)00518-0 · Cited by 137
Peterson, L. F., Boyapati, A., Ahn, E.-Y. E., Biggs, J. R., Okumura, A. J., Lo, M., Yan, M., & Zhang, D. (2007) · Blood · doi:10.1182/blood-2006-11-019265 · Cited by 135
Self-citationAML1-ETO reprograms hematopoietic cell fate by downregulatingsclexpression
Yeh, J.-R. J., Munson, K. M., Chao, Y. L., Peterson, Q. P., MacRae, C. A., & Peterson, R. T. (2007) · Development · doi:10.1242/dev.008904 · Cited by 126
ISG15: a ubiquitin-like enigma
Chinh, T.-T. (2005) · Frontiers in bioscience · doi:10.2741/1730 · Cited by 126
Tsuji, K., Ito, Y., & Noda, M. (1998) · Bone · doi:10.1016/s8756-3282(97)00267-6 · Cited by 134
Zaidi, S. K., Dowdy, C. R., van Wijnen, A. J., Lian, J. B., Raza, A., Stein, J. L., Croce, C. M., & Stein, G. S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1567 · Cited by 115
Transcription factor fusions in acute leukemia: variations on a theme
Scandura, J. M., Boccuni, P., Cammenga, J., & Nimer, S. D. (2002) · Oncogene · doi:10.1038/sj.onc.1205315 · Cited by 132
Stem cell exhaustion due to Runx1 deficiency is prevented by Evi5 activation in leukemogenesis
Jacob, B., Osato, M., Yamashita, N., Wang, C. Q., Taniuchi, I., Littman, D. R., Asou, N., & Ito, Y. (2010) · Blood · doi:10.1182/blood-2009-07-232249 · Cited by 108
TEL-AML1 Corrupts Hematopoietic Stem Cells to Persist in the Bone Marrow and Initiate Leukemia
Schindler, J. W., Buren, D. V., Foudi, A., Krejci, O., Qin, J., Orkin, S. H., & Hock, H. R. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.04.019 · Cited by 122
Zhang, Y., Strissel, P. L., Strick, R., Chen, J., Nucifora, G., Beau, M. M. L., Larson, R. A., & Rowley, J. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.042702899 · Cited by 117
Buchholz, F., Refaeli, Y., Trumpp, A., & Bishop, J. M. (2000) · EMBO Reports · doi:10.1093/embo-reports/kvd027 · Cited by 108
Martens, J. H. A., Mandoli, A., Simmer, F., Wierenga, B.-J., Saeed, S., Singh, A. A., Altucci, L., Vellenga, E., & Stunnenberg, H. G. (2012) · Blood · doi:10.1182/blood-2012-05-429050 · Cited by 103
He, L.-Z., Merghoub, T., & Pandolfi, P. P. (1999) · Oncogene · doi:10.1038/sj.onc.1203088 · Cited by 116
Mechanism of leukemogenesis by the inv(16) chimeric gene CBFB/PEBP2B-MHY11
Shigesada, K., van de Sluis, B., & Liu, P. P. (2004) · Oncogene · doi:10.1038/sj.onc.1207748 · Cited by 109
Translocations, cancer and the puzzle of specificity
Barr, F. G. (1998) · Nature Genetics · doi:10.1038/475 · Cited by 101
The core-binding factor leukemias: lessons learned from murine models
Downing, J. R. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00018-7 · Cited by 106
Prognostic Implications of Gene Mutations in Acute Myeloid Leukemia With Normal Cytogenetics
Gaidzik, V. I., & Döhner, K. (2008) · Seminars in Oncology · doi:10.1053/j.seminoncol.2008.04.005 · Cited by 110
Shimada, H., Ichikawa, H., Nakamura, S., Katsu, R., Iwasa, M., Kitabayashi, I., & Ohki, M. (2000) · Blood · doi:10.1182/blood.v96.2.655 · Cited by 93
Jakubowiak, A. J., Pouponnot, C., Berguido, F. J., Frank, R. C., Mao, S. S., Massagué, J., & Nimer, S. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000485200 · Cited by 105
GENETICS OF ERYTHROPOIESIS: Induced Mutations in Mice and Zebrafish
Orkin, S. H., & Zon, L. I. (1997) · Annual Review of Genetics · doi:10.1146/annurev.genet.31.1.33 · Cited by 90
p53 signaling in response to increased DNA damage sensitizes AML1-ETO cells to stress-induced death
Krejci, O., Wunderlich, M., Geiger, H., Chou, F., Schleimer, D., Jansen, M., Andreassen, P. R., & Mulloy, J. C. (2007) · Blood · doi:10.1182/blood-2007-06-093682 · Cited by 100
Stem cell expression of the AML1/ETO fusion protein induces a myeloproliferative disorder in mice
Fenske, T. S., Pengue, G., Mathews, V., Hanson, P. T., Hamm, S. E., Riaz, N., & Graubert, T. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400751101 · Cited by 101
Telfer, J. C., & Rothenberg, E. V. (2001) · Developmental Biology · doi:10.1006/dbio.2000.9991 · Cited by 100
Chyla, B., Moreno–Miralles, I., Steapleton, M. A., Thompson, M. A., Bhaskara, S., Engel, M. E., & Hiebert, S. W. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00404-08 · Cited by 91
Zebrafish a genetic model for vertebrate organogenesis and human disorders
Paw, B. H. (2003) · Frontiers in bioscience · doi:10.2741/1092 · Cited by 100
Common themes in the pathogenesis of acute myeloid leukemia
Alcalay, M., Orleth, A., Sebastiani, C., Meani, N., Chiaradonna, F., Casciari, C., Sciurpi, M. T., Gelmetti, V., Riganelli, D., Minucci, S., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204642 · Cited by 107
Metadata
- Authors
- Yergeau, D. A., Hetherington, C. J., Wang, Q., Zhang, P., Sharpe, A. H., Binder, M., Marín-Padilla, M., Tenen, D. G., Speck, N. A., & Zhang, D.-E.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Dartmouth College (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Zhang, Dong-Er
- Venue
- Nature Genetics
- Published
- 1997-03
- Volume
- 15
- Issue
- 3
- Pages
- 303-306
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2054210423
- Cited by
- 346
- References
- 32
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 6 · 2022: 3 · 2021: 1 · 2020: 4 · 2019: 4 · 2018: 2 · 2017: 12 · 2016: 4 · 2015: 10 · 2014: 5 · 2013: 7 · 2012: 15
- FWCI
- 13.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ns022897-10)
- National Cancer Institute (CA 41456, R01CA041456)
- National Institute of Neurological Disorders and Stroke (NS22897)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (P030AR42689)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Keywords
- AML1-ETO fusion gene, acute myeloid leukemia, embryonic lethality, macrophage differentiation, leukemogenesis, CBFB
- MeSH terms
- RUNX1 Translocation Partner 1 Protein, Animals, Chimera, Chromosome Mapping, Chromosomes, Human, Pair 21, Chromosomes, Human, Pair 8, Cloning, Molecular, Crosses, Genetic, DNA-Binding Proteins, Exons, Female, Fetal Death, Hematopoiesis, Genetic Carrier Screening, Humans, Leukemia, Myeloid, Liver, Male, Mice, Inbred C57BL, Mice, Mutant Strains, Proto-Oncogene Proteins, Transcription Factors, Translocation, Genetic, Yolk Sac, Core Binding Factor Alpha 2 Subunit, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.